Luvo Health vs bmiMD: Tirzepatide, semaglutide and pricing
Quick verdict: Luvo Health emphasizes clinician-reviewed programs with tirzepatide and multiple semaglutide formats and cancel-anytime support, while bmiMD centers on compounded tirzepatide subscriptions with explicit multi-month pricing and free shipping.
View Luvo Health treatment options
Overview: Luvo Health vs bmiMD
The comparison between Luvo Health vs bmiMD comes down to three main differences supported by the sources: types of medications offered, pricing and billing commitments, and shipping and service terms. Both note that treatment is available only when a licensed clinician determines it is medically appropriate and both include regulatory notes that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality.
1. Medications and formats
Luvo Health documents availability of tirzepatide injection plus semaglutide injections and semaglutide tablets and lists microdosing options for tirzepatide and semaglutide. bmiMD focuses on compounded tirzepatide (GLP-1/GIP). Both providers reference compounded medications when applicable and include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Explore bmiMD tirzepatide plans
2. Pricing model and commitments
Luvo Health materials show ongoing support, dose adjustments based on clinical response and a cancel-anytime statement, but captured details did not verify exact starting price. bmiMD provides explicit month-to-month and multi-month pricing for compounded tirzepatide: $179 month-to-month; $159 per month for a three-month plan; $149 per month for six months; and $139 per month for a 12-month plan. bmiMD also highlights that the lowest monthly price requires a 12-month commitment and that total prepaid charge should be confirmed.
See Luvo Health support and dosing
3. Shipping, refills and clinician access
bmiMD lists free subscription shipping on every order, online refills and 24/7 clinician access. Luvo Health indicates ongoing support, dose changes and clinician review for treatment availability. The bmiMD evidence highlights online refills and delivery confirmed in captured landing-page notes.
Direct comparison table
| Criteria | Luvo Health | bmiMD |
|---|---|---|
| Primary offerings | Tirzepatide injection; semaglutide injection and tablets; microdosing options | Compounded tirzepatide (GLP-1/GIP) |
| Pricing details | Not verified on captured landing page; ongoing support and dose adjustments listed | $179/mo month-to-month; $159/mo 3-month; $149/mo 6-month; $139/mo 12-month |
| Commitment | Cancel anytime; dose adjustments based on clinical response | Multi-month plans; lowest price requires 12-month commitment; confirm total prepaid charge |
| Shipping and refills | Ongoing support and delivery implied; details not verified | Free subscription shipping; online refills and delivery |
| Clinician access and eligibility | Treatment available only when a licensed clinician determines it is medically appropriate | Treatment available only when a licensed clinician determines it is medically appropriate; 24/7 clinician access noted |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Practical differences to consider
If you prioritize specific FDA-labelled formats or multiple medication formats, Luvo Health lists both tirzepatide injection and semaglutide in multiple forms and microdosing options. If you prioritize explicit month-to-month pricing tiers, free shipping and lower long-term monthly equivalents subject to a longer commitment, bmiMD provides clear tiered pricing and free subscription shipping in the captured evidence.
Compare bmiMD pricing and plans
Safety, verification and reservations
Both sources include the regulatory qualifier that compounded medications, when offered, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Luvo Health explicitly repeats that compounded medications are prepared by licensed pharmacies and are not reviewed or approved by the FDA. bmiMD notes that medications are prepared in state-licensed pharmacies and independently verified in FDA- and DEA-registered labs in the captured landing-page text, and it advises confirming total prepaid charges for multi-month plans.
Conclusion: Luvo Health vs bmiMD
For a quick choice: Luvo Health is centered on clinician-reviewed programs offering tirzepatide plus semaglutide formats and emphasizes ongoing support and cancel-anytime terms. bmiMD is focused on compounded tirzepatide subscriptions with explicit pricing tiers from $179 to $139 per month and free subscription shipping, with the lowest price tied to a 12-month commitment.
Choose Luvo Health if you want clinician-reviewed access to tirzepatide and semaglutide in multiple formats and prefer cancel-anytime ongoing support, and choose bmiMD if you want clear tiered monthly pricing, free subscription shipping and are willing to confirm multi-month commitments and prepaid totals. Compare Luvo Health vs bmiMD based on which of these supported differences matters most to you.